Delivery Order SPE2DB22D2206-SPE2DB25FHM03
Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,190.29 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. This is a non-set-aside competitive award with an ultimate completion date of August 27, 2025, and performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Olopatadine HCL 0.1% eye drops (5 mL units) with a ceiling value of $1,148.94. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,708.86 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. This firm fixed price delivery order, awarded on August 8, 2025, is set to be completed by August 11, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, demonstrating AmerisourceBergen's capability to fulfill...
- The Defense Logistics Agency awarded a Delivery Order contract valued at $2,228.42 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5mL quantities, valued at $2,587.17. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,757.44 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops (5 mL) under a firm fixed-price contract. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-competitive delivery order with no set-aside designation. Performance of this order will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% Eye Drops (5ML) with a ceiling value of $2,789.33. The contract, which is a firm fixed-price delivery order, was awarded on May 9, 2025, with an ultimate completion date of May 12, 2025. This award does not include a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,380.55 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops (5 mL units). This firm fixed price, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract represents a non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $2,112.82 firm-fixed-price contract has a performance period through May 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,825.66 firm fixed price delivery order is for the supply of Olopatadine HCL 0.1% eye drops, a prescription ophthalmic medication. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an...